Slate Path Capital LP insider trades

Open-market stock purchases and sales by Slate Path Capital LP, 10% Owner at Cyclerion Therapeutics, Inc, from SEC Form 4 filings since Jun 3, 2021.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • CYCN Cyclerion Therapeutics, Inc: 1 buy, 1 sale, last Nov 21, 2024

Get free alerts when Slate Path Capital LP files a new trade →